Friday, April 24, 2015

10:30-11:20
Lecture session
Chairperson
Boulos Haraoui, Canada
10:30
Epigenetics and RA
Steffen Gay, Switzerland

10:50
Biologics during pregnancy and lactation
Carl Laskin, Canada
11:10
Discussion

13:50-14:40
Debate: Monotherapy biologics vs. combination biologics with MTX/DMARDs
Chairperson
Louis Bessette, Canada
13:50
Con
Joel M. Kremer, USA 

14:10
Pro
Janet Pope, Canada 
14:30

Discussion


14:40-15:30
Lecture session
Chairperson
Boulos Haraoui, Canada
14:40 
Immune Dysregulation in pre-clinical RA
William Rigby, USA
15:00
Biomarkers in daily clinical practice
Gilles Boire, Canada
15:20

Discussion


 15:50-16:40
Debate: How best to assess disease activity / remission in daily clinical practice
 Chairperson
Gilles Boire, Canada
15:50
Patient’s outcomes
Yusuf Yazici
USA  
16:10
Physician’s outcomes
Janet Pope, Canada 
16:30

Discussion


17:10-18:10
Round Table: Which biologic/oral agent to use first?
Chairperson
Edith Villeneuve, Canada
17:10 Anti-TNF
Bruno Fautrel
, France 
17:25 Alternate MOA
William Rigby
, USA 
17:40 Oral agent
Louis Bessette
, Canada 
17:55 Discussion

Saturday, April 25, 2015

10:30-11:20
Lecture session
Chairperson
Janet Pope, Canada
10:30
Poor prognostic markers in RA
Bruno Fautrel, France
10:50

Management of ILD in RA
William Rigby, USA 

11:10

Discussion


 13:40-14:30
Debate: Is there still a place for oral corticosteroids in RA?
 Chairperson
Bernard Combe, France
13:40
Pro
Boulos Haraoui, Canada  
14:00
Con
Gilles Boire, Canada 
14:20

Discussion


 14:30-15:20
Debate: Which target to use in a T2T strategy
 Chairperson
Gilles Boire, Canada
14:30
Clinical targets
Daniel Aletaha, Austria
14:50

Imaging targets
Walter Grassi, Italy

15:10

Discussion


15:40-16:30
Joint OA/RA Session: Cardiovascular outcomes in OA and RA
Chairpersons

Jean-Pierre Raynauld, Canada
Jean-Pierre Pelletier, Canada

15:40

Cardiovascular risk factors associated with osteoarthritis
Guy Leclerc, Canada 

16:00

Cardiovascular effect of commonly used medications in the management of RA
Boulos Haraoui, Canada 

16:20

Discussion


 17:00-18:00
Round Table: How to interpret Cohort / Registry data
 Chairperson

Louis Bessette, Canada

 

Speakers:

17:00
Bernard Combe (ESPOIR), France
17:12
Joel M. Kremer (CORRONA), USA
17:24 Claire Bombardier (OBRI), Canada
17:36 Denis Choquette (RhumaData®), Canada
17:48 Discussion